1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


TABLE 4: 
Differentiation of histologic tumor types
ParameterHGA (n = 8)MET (n = 8)LGA (n = 12)NAG (n = 8)MNG (n = 7)DNET (n = 3)*GRN (n = 3)*F Score†P Value†
MeanSDMeanSDMeanSDMeanSDMeanSDMeanSDMeanSD
NAA/Cho0.550.360.740.200.670.250.640.310.850.351.980.230.900.491.105NS‡
NAA/Cr0.960.401.110.311.040.441.080.411.420.611.710.261.140.371.240NS‡
NAA/Cho + Cr0.340.180.440.110.400.140.390.140.520.200.920.120.500.221.364NS‡
Cho/Cr2.050.851.530.351.610.451.850.701.760.740.860.051.350.260.910NS‡
Lipid/Cr0.220.140.760.250.190.100.330.210.370.220.250.060.130.0313.210.000§
Lactate/Cr0.270.260.440.110.160.190.320.250.000.000.000.000.000.003.691.012|
Lactate/lipid1.271.120.600.110.780.850.790.600.330.560.000.000.000.001.619NS
Alanin/Cr0.000.000.000.000.000.000.000.000.390.210.000.000.000.0032.104.000
ADCT89.4412.9884.887.22112.589.44119.4414.05107.148.03116.006.93100.6717.7416.537.000#
ADCPT128.4426.83168.6919.86169.6340.59163.5017.56101.2939.4191.507.1280.507.097.416.000**
  • Note.—HGA indicates high-grade glioma; MET, metastasis; LGA, low-grade glioma; NAG, nonastrocytic gliomas; MNG, meningioma; DNET, dysembryoplastic neuroepithelial tumor; GRN, granuloma; ADCT, calculated ADC values from tumoral area; ADCPT, calculated ADC values from peritumoral area; NS, not significance.
  • * DNET and GRN were excluded from statistical comparison because of their low sample number.
  • † F score and P values were obtained by using Tukey pairwise post hoc test.
  • ‡ Although the omnibus test was statistically significant, none of the pairwise post hoc tests reached significance.
  • § MET > HGA, MET > LGA, MET > NAG P < .001; MET > MNG P < .05; otherwise NS.
  • | MET > LGA, MET > MNG P < .05; otherwise NS.
  •  MNG > HGA, MNG > MET, MNG > LGA, MNG > NAG P < .001; otherwise NS.
  • # LGA > HGA, LGA > MET, NAG > HGA, NAG > MET P < .001; MNG > HGA, MNG > MET P < .05; otherwise NS.
  • ** LGA > MNG P < .001; LGA > HGA, MET > MNG, NAG > MNG P < .05; otherwise NS.